HALO logo
halo search icon
Plus Therapeutics, Inc.
Plus Therapeutics, Inc.
PSTV · NAS

Plus Therapeutics, Inc.

US$6.89

Price Arrow0.46 (7.15%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Capital EfficiencyHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Plus Therapeutics, Inc. Overview

PSTV Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

About PSTV

icon

Telephone

1.210.974.6900

icon

Address

Suite 160, 2710 Reed Road, Houston, TX 77051

Description

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

PSTV Price Chart

Key Stats

Market Cap

US$44.26M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.9 - 23.42

Trade Value (12mth)

US$1,840,871.00

1 week

22.48%

1 month

-15.62%

YTD

-53.66%

1 year

-17.83%

All time high

28153100.00

Key Fundamentals

EPS 3 yr Growth

-97.50%

EBITDA Margin

-284.90%

Operating Cashflow

-$21m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

-4.10

Quick Ratio

1.20

Other Data

Shares Outstanding (Fully Diluted)

7m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

PSTV Announcements

Latest Announcements

DateAnnouncements
16 May 26
16 May 26
16 May 26
16 May 26
16 May 26

PSTV Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-105.99-48.86-7.19locklocklock
EPS (Fully Diluted)
$locklocklocklock-105.99-58.52-7.19locklocklock
Growth
%locklocklocklock63.453.985.3locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Plus Therapeutics, Inc. (PSTV:NAS)?
Halo FAQ
The current share price of Plus Therapeutics, Inc. (PSTV:NAS) is USD$6.89.
What is the 52-week high share price for Plus Therapeutics, Inc. (PSTV:NAS)?
Halo FAQ
The 52-week high share price for Plus Therapeutics, Inc. (PSTV:NAS) is USD$23.42.
What is the 52-week low share price for Plus Therapeutics, Inc. (PSTV:NAS)?
Halo FAQ
The 52-week low share price for Plus Therapeutics, Inc. (PSTV:NAS) is USD$2.90.
What is the dividend yield for Plus Therapeutics, Inc. (PSTV:NAS)?
Halo FAQ
Plus Therapeutics, Inc. (PSTV:NAS) does not pay a dividend.
What was Plus Therapeutics, Inc. (PSTV:NAS) last dividend payment?
Halo FAQ
Plus Therapeutics, Inc. (PSTV:NAS) does not pay a dividend.
What is the franking level for Plus Therapeutics, Inc. (PSTV:NAS)?
Halo FAQ
Plus Therapeutics, Inc. (PSTV:NAS) has a franking level of 0.00%.
In which sector is Plus Therapeutics, Inc. (PSTV:NAS) classified?
Halo FAQ
Plus Therapeutics, Inc. (PSTV:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.